BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30836220)

  • 1. Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland.
    Ruiz de Azua Unzurrunzaga G; Brewster DH; Wild SH; Sivalingam VN
    Cancer Epidemiol; 2019 Apr; 59():227-231. PubMed ID: 30836220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hysterectomy on the age-specific incidence of cervical and uterine cancer in Germany and other countries.
    Stang A
    Eur J Public Health; 2013 Oct; 23(5):879-83. PubMed ID: 22711786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008.
    Siegel RL; Devesa SS; Cokkinides V; Ma J; Jemal A
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):25-31. PubMed ID: 23125334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010.
    Stang A; Hawk H; Knowlton R; Gershman ST; Kuss O
    Ann Epidemiol; 2014 Nov; 24(11):849-54. PubMed ID: 25241148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.
    Redburn JC; Murphy MF
    BJOG; 2001 Apr; 108(4):388-95. PubMed ID: 11305546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
    Jamison PM; Noone AM; Ries LA; Lee NC; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):233-41. PubMed ID: 23239812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.
    Clarke MA; Devesa SS; Hammer A; Wentzensen N
    JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in hysterectomy-corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?
    Gustafson LW; Booth BB; Kahlert J; Ørtoft G; Mejlgaard E; Clarke MA; Wentzensen N; Rositch AF; Hammer A
    Int J Cancer; 2021 Feb; 148(3):584-592. PubMed ID: 32683690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy.
    Merrill RM; Layman AB; Oderda G; Asche C
    Ann Epidemiol; 2008 Mar; 18(3):253-60. PubMed ID: 18280923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
    Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
    Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States.
    Temkin SM; Kohn EC; Penberthy L; Cronin KA; Rubinsak L; Dickie LA; Minasian L; Noone AM
    Cancer Causes Control; 2018 May; 29(4-5):427-433. PubMed ID: 29497884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two methods based on cross-sectional data for correcting corpus uterine cancer incidence and probabilities.
    Merrill RM; Lyon JL; Wiggins C
    BMC Cancer; 2001; 1():13. PubMed ID: 11686855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal and age-dependent patterns of hysterectomy-corrected cervical cancer incidence rates in Denmark: a population-based cohort study.
    Hammer A; Kahlert J; Rositch A; Pedersen L; Gravitt P; Blaakaer J; Soegaard M
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):150-157. PubMed ID: 27861705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
    Rositch AF; Nowak RG; Gravitt PE
    Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysterectomy trends in Australia, 2000-2001 to 2013-2014: joinpoint regression analysis.
    Wilson LF; Pandeya N; Mishra GD
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1170-1179. PubMed ID: 28627047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted cancer-incidence rates (United States).
    Merrill RM; Feuer EJ
    Cancer Causes Control; 1996 Sep; 7(5):544-52. PubMed ID: 8877053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing trend and changing indications of hysterectomy in Finland.
    Hakkarainen J; Nevala A; Tomás E; Nieminen K; Malila N; Pitkäniemi J; Auranen A
    Acta Obstet Gynecol Scand; 2021 Sep; 100(9):1722-1729. PubMed ID: 33797081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy prevalence and death rates for cervical cancer--United States, 1965-1988.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jan; 41(2):17-20. PubMed ID: 1728728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rising frequency of hysterectomy: its effect on uterine cancer rates.
    Lyon JL; Gardner JW
    Am J Epidemiol; 1977 May; 105(5):439-43. PubMed ID: 860706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.